Patient Guide: A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 15 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06892288
Status: ACTIVE_NOT_RECRUITING
Condition: Phosphomannomutase 2 Deficiency, PMM2-CDG
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 15 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Minneapolis, Minnesota
  • New York, New York
  • Philadelphia, Pennsylvania
  • • And 12 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily